Literature DB >> 34079095

Social determinants of atrial fibrillation.

Utibe R Essien1, Jelena Kornej2, Amber E Johnson3, Lucy B Schulson4, Emelia J Benjamin2,5, Jared W Magnani3.   

Abstract

Atrial fibrillation affects almost 60 million adults worldwide. Atrial fibrillation is associated with a high risk of cardiovascular morbidity and death as well as with social, psychological and economic burdens on patients and their families. Social determinants - such as race and ethnicity, financial resources, social support, access to health care, rurality and residential environment, local language proficiency and health literacy - have prominent roles in the evaluation, treatment and management of atrial fibrillation. Addressing the social determinants of health provides a crucial opportunity to reduce the substantial clinical and non-clinical complications associated with atrial fibrillation. In this Review, we summarize the contributions of social determinants to the patient experience and outcomes associated with this common condition. We emphasize the relevance of social determinants and their important intersection with atrial fibrillation treatment and outcomes. In closing, we identify gaps in the literature and propose future directions for the investigation of social determinants and atrial fibrillation.
© 2021. Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 34079095      PMCID: PMC8516747          DOI: 10.1038/s41569-021-00561-0

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  133 in total

1.  Rural-urban disparities in smoking patterns among Chinese adults: a social-ecological approach.

Authors:  Yen-Han Lee; Ting Fang Alvin Ang; Hsien-Chang Lin; Yen-Chang Chang
Journal:  J Ethn Subst Abuse       Date:  2019-07-04       Impact factor: 1.507

2.  Race Effects in CVD Prediction Models.

Authors:  Utibe R Essien; Larry R Jackson
Journal:  J Gen Intern Med       Date:  2019-04       Impact factor: 5.128

3.  Socioeconomic status and the development of atrial fibrillation in Hispanics, African Americans and non-Hispanic whites.

Authors:  Eric Shulman; Faraj Kargoli; Philip Aagaard; Ethan Hoch; Luigi Di Biase; John Fisher; Jay Gross; Soo Kim; Kevin J Ferrick; Andrew Krumerman
Journal:  Clin Cardiol       Date:  2017-06-09       Impact factor: 2.882

4.  Racial/Ethnic differences in ischemic stroke rates and the efficacy of warfarin among patients with atrial fibrillation.

Authors:  Albert Yuh-Jer Shen; Janis F Yao; Somjot S Brar; Michael B Jorgensen; Xunzhang Wang; Wansu Chen
Journal:  Stroke       Date:  2008-07-17       Impact factor: 7.914

5.  Variation in the Use of Warfarin and Direct Oral Anticoagulants in Atrial Fibrillation and Associated Cost Implications.

Authors:  Benjamin A Rodwin; Joseph A Salami; Erica S Spatz; Javier Valero-Elizondo; Salim S Virani; Ron Blankstein; Michael J Blaha; Khurram Nasir; Nihar R Desai
Journal:  Am J Med       Date:  2018-10-02       Impact factor: 4.965

6.  Effectiveness of interventions to improve cardiovascular healthcare in rural areas: a systematic literature review of clinical trials.

Authors:  Isabel Ruiz-Pérez; Ángel Bastos; Maria Jesús Serrano-Ripoll; Ignacio Ricci-Cabello
Journal:  Prev Med       Date:  2018-12-28       Impact factor: 4.018

7.  Racial differences in the prevalence and outcomes of atrial fibrillation among patients hospitalized with heart failure.

Authors:  Kevin L Thomas; Jonathan P Piccini; Li Liang; Gregg C Fonarow; Clyde W Yancy; Eric D Peterson; Adrian F Hernandez
Journal:  J Am Heart Assoc       Date:  2013-09-26       Impact factor: 5.501

8.  Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial.

Authors:  Michael D Ezekowitz; Charles V Pollack; Jonathan L Halperin; Richard D England; Sandra VanPelt Nguyen; Judith Spahr; Maria Sudworth; Nilo B Cater; Andrei Breazna; Jonas Oldgren; Paulus Kirchhof
Journal:  Eur Heart J       Date:  2018-08-21       Impact factor: 29.983

9.  Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation.

Authors:  Inmaculada Hernandez; Meiqi He; Nemin Chen; Maria M Brooks; Samir Saba; Walid F Gellad
Journal:  J Am Heart Assoc       Date:  2019-06-13       Impact factor: 5.501

10.  Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge.

Authors:  Giuseppe Lippi; Fabian Sanchis-Gomar; Gianfranco Cervellin
Journal:  Int J Stroke       Date:  2020-01-19       Impact factor: 5.266

View more
  9 in total

1.  Racial and Ethnic Representation in Atrial Fibrillation Trials: CABANA and Beyond.

Authors:  Tarryn Tertulien; Jared W Magnani; Utibe R Essien
Journal:  J Am Coll Cardiol       Date:  2021-11-09       Impact factor: 24.094

2.  Association of Neighborhood Disadvantage and Anticoagulation for Patients with Atrial Fibrillation in the Veterans Health Administration: the REACH-AF Study.

Authors:  Annie McDermott; Nadejda Kim; Leslie R M Hausmann; Jared W Magnani; Chester B Good; Terrence M A Litam; Maria K Mor; Toluwa D Omole; Walid F Gellad; Michael J Fine; Utibe R Essien
Journal:  J Gen Intern Med       Date:  2022-09-23       Impact factor: 6.473

3.  Design and rationale of the mobile health intervention for rural atrial fibrillation.

Authors:  Jared W Magnani; Danielle Ferry; Gretchen Swabe; Deborah Martin; Xirun Chen; Maria M Brooks; Everlyne Kimani; Michael K Paasche-Orlow; Stefán Ólafsson; Timothy Bickmore; Samar R El Khoudary
Journal:  Am Heart J       Date:  2022-06-09       Impact factor: 5.099

4.  The atrial fibrillation paradox -connecting hypertension to atrial disease and stroke.

Authors:  Phil Mendys; Larry R Jackson; Elsayed Z Solimon; George Howard; Keith Ferdinand
Journal:  Am J Prev Cardiol       Date:  2021-10-21

5.  The association of education and household income with the lifetime risk of incident atrial fibrillation: The Framingham Heart study.

Authors:  Feven Ataklte; Quixi Huang; Jelena Kornej; Favel Mondesir; Emelia J Benjamin; Ludovic Trinquart
Journal:  Am J Prev Cardiol       Date:  2022-01-12

6.  American Journal of Preventive Cardiology: Area Deprivation Index and Oral Anticoagulation in New Onset Atrial Fibrillation.

Authors:  Toluwa D Omole; Jianuhi Zhu; William Garrard; Floyd W Thoma; Suresh Mulukutla; Annie McDermott; Brandon M Herbert; Utibe R Essien; Jared W Magnani
Journal:  Am J Prev Cardiol       Date:  2022-04-27

7.  Impact of social determinants of health on anticoagulant use among patients with atrial fibrillation: Systemic review and meta-analysis.

Authors:  Rasha Khatib; Nicole Glowacki; John Byrne; Peter Brady
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

8.  Socioeconomic factors and bleeding events in patients with incident atrial fibrillation: A Finnish nationwide cohort study.

Authors:  Konsta Teppo; Jussi Jaakkola; Fausto Biancari; Olli Halminen; Miika Linna; Jukka Putaala; Pirjo Mustonen; Janne Kinnunen; Santeri Jolkkonen; Mikko Niemi; Juha Hartikainen; K E Juhani Airaksinen; Mika Lehto
Journal:  Int J Cardiol Heart Vasc       Date:  2022-10-10

9.  Association Between Neighborhood-Level Poverty and Incident Atrial Fibrillation: a Retrospective Cohort Study.

Authors:  Utibe R Essien; Megan E McCabe; Kiarri N Kershaw; Quentin R Youmans; Michael J Fine; Clyde W Yancy; Sadiya S Khan
Journal:  J Gen Intern Med       Date:  2021-07-08       Impact factor: 6.473

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.